The EURenOmics Consortium
EURenOmics integrates several established consortia devoted to rare kidney diseases with eminent need and potential for diagnostic and therapeutic progress (ie, steroid resistant nephrotic syndrome, membranous nephropathy, tubulopathies, complement disorders such a haemolytic uraemic syndrome, and congenital kidney malformations).
The consortium has access to the largest clinical cohort assembled to date (collectively >10,000 patients). For this cohort detailed phenotypic information and comprehensive biorepositories containing DNA, blood, urine, amniotic fluid and kidney tissue are available.
Horizon 2020 partnering
Are you looking for an SME or subcontractor as partner for your project proposal in line with HORIZON 2020?
Multiplicom is a dynamic and reliable partner for developing state of the art Multiplex PCR assays that are to be combined with massively parallel sequencing.
At Multiplicom we have ample expertise in assay development directed to genomic DNA, FFPE-derived DNA, cell-free DNA, RNA and miRNA.